Shares of Medtronic PLC MDT dropped 0.96% to $85.71 Tuesday, on what proved to be an all-around mixed trading session for the ...

Shares of Medtronic PLC MDT were unchanged Monday, on what proved to be an all-around mixed trading session for the stock ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Medtronic (MDT – Research Report) today. The company’s shares opened ...

Medtronic's Q2 results beat Wall Street expectations, with revenue up 5% year-over-year. Click here to find out why I have a ...

Medtronic (NYSE:MDT – Free Report) had its price objective decreased by Wells Fargo & Company ... Its Cardiovascular ...

NORTHAMPTON, MA / ACCESSWIRE / November 21, 2024 /By Ken Washington, Chief Technology and Innovation Officer, and Raman Venkatesh, Chief Sustainability Officer, MedtronicWhen you think about healthcar ...

Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on Medtronic (MDT) to $98 from $106 and keeps an Overweight rating on the ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations ... performance from franchises like TAVR, PFA, leadless pacemakers, diabetes, spine, and neuromodulation, just ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Presentation Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations at Medtronic Good morning. I'm Ryan ...

Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024.

Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release ...